[1] S. Tanya and H. Howard, Levadopa: A Pharmacologic Miracle Four Decades Later, in Parkinson's Disease: Diagnosis and Clinical Management. Demos Medical Publishing, New York (2008). 21-49.
[2] A.K. Singh, R.C. Bharati, N.C. Manibhushan, A. Pedpati, African Journal of Agricultural Research, 8, 50 (2013). 6634-6641.
[3] R.A. Hauser, Eur Neurol (2009). 62, 1-8.
[4] A. Abbott, Nature, 466 (2010). S6-S7.
[5] H. Ehringer and O. Hornykiewicz, Wien Klin Wochenschr 38 (1960).1236-1239.
[6] W. Birkmayer and O. Hornykiewicz, Wien Klin Wochenschr 73 (1961). 787-788.
[7] Q. Huang, M. Liu, R. Guo, L. Mao, Q. Wan, G. Zeng, H. Huang, F. Deng, X. Zhang, Y. Wei, Journal of Materials Science 51, 21 (2016). 9625-9637.
[8] G.C. Cotzias, P.S. Papavasiliou, R. Gellene, The New England Journal of Medicine 5 (1969). 272-278.
[9] U.W. Madison, Synthetic scheme for total synthesis of DOPA, L-(Monsanto). Available from: URL: http://www.chem.wisc.edu/areas/reich/syntheses/dopa-monsanto-knowles.htm (2013).
[10] S.K. William, Accounts of Chemical Research16 (1983). 106-112.
[11] K. Min, D.H. Park, Y.J. Yoo, J Biotechnol 146, 1-2 (2010). 40-44.
[12] Luigi Bernardi, Via Pinerolo, Onofrio Goffredo, Via Cremosano, US Patent 3717673 (1979).
[13] Dakin oxidation from: URL: https://en.wikipedia.org/wiki/Dakin_oxidation (2016).
[14] M.H. Sarvari and H. Sharghi, J. Org. Chem. 69 (2004). 6953-695.
)